NEO214
Product Specifications
CAS Number
1361198-80-2
Target
MTOR, Autophagy
Related Pathways
Autophagy, PI3K/Akt/mTOR signaling
Bioactivity
NEO214, an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram and perillyl alcohol, exhibits anti-cancer activity and blood-brain barrier (BBB) permeability. It prevents autophagy-lysosome fusion, blocking autophagic flux and triggering glioma cell death via mTOR activation and TFEB (Transcription Factor EB) aggregation. NEO214 inhibition of Macroautophagy/autophagy in glioblastoma cells may overcome chemotherapy resistance in glioblastoma [1].
Smiles
C(OCC=1CC[C@H](C(C)=C)CC1)(=O)N2CC(CC2=O)C3=CC(OC4CCCC4)=C(OC)C=C3
Molecular Formula
C27H35NO5
Molecular Weight
453.57
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AZA3KNS3-APC 100 µg/Vial
Anti-Zebrafish IHHA Antibody Picoband® APC Conjugated
Sign In for Pricing
View Details